SFI
NURO

Susquehanna Fundamental Investments’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,778
Closed -$144K – 1819
2021
Q3 		$144K Buy
+1,778
New +$159K ﹤0.01% 1587

Other funds holding NURO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SC
Stephens Consulting Flint, Michigan $309M AUM 14.46% 1-Year Est. Return

Susquehanna Fundamental Investments's NURO Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2021, closing a stake of 1,778 shares — an estimated $144K sold.

Susquehanna Fundamental Investments first reported a position in NURO in Q3 2021 and held it in 1 quarter. The position peaked at $144K in Q3 2021. 17 funds tracked by Wall St. Rank hold NURO as of Q4 2021.

  • Susquehanna Fundamental Investments reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 1,778 NeuroMetrix, Inc. Common Stock shares in Q4 2021, an estimated $144K.
  • Susquehanna Fundamental Investments first reported a position in NeuroMetrix, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Susquehanna Fundamental Investments's NeuroMetrix, Inc. Common Stock position peaked at $144K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.